JAMES LIM: Open Payments
NPI 1326167883 · IRWIN, PA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$114,820 in 203 payments from 12 companies in 2025. Trend: 2023 $537 · 2024 $72,819 · 2025 $114,820
Honoraria: $85,200Travel & lodging: $25,063Food & beverage: $4,557
| Company | Payments | Amount |
|---|---|---|
| Braeburn Inc. | 179 | $114,412 |
| Novo Nordisk Inc | 8 | $142 |
| Takeda Pharmaceuticals U.S.A., Inc. | 5 | $75 |
| Indivior Inc. | 2 | $38 |
| E.R. Squibb & Sons, L.L.C. | 2 | $35 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 1 | $19 |
| Axsome Therapeutics, Inc. | 1 | $18 |
| Daiichi Sankyo Inc. | 1 | $18 |
| ARS Pharmaceuticals Operations, Inc. | 1 | $17 |
| AstraZeneca Pharmaceuticals LP | 1 | $16 |
Products named: BRIXADI, TRINTELLIX, Ozempic, SUBLOCADE, ELIQUIS, Rybelsus, CAPLYTA, Auvelity.
Industry payments across PA — which companies pay providers there.
